Silverarc Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.8M	Buy	888,987 +246,088	+38%	+$5.35M	2.45%	17
2025 Q4	$13.5M	Buy	642,899 +179,191	+39%	+$3.13M	1.95%	17
2025 Q3	$7.13M	Buy	463,708 +60,744	+15%	+$795K	1.03%	32
2025 Q2	$3.77M	Sell	402,964 -906,260	-69%	-$9.97M	0.77%	34
2025 Q1	$16.1M	Buy	1,309,224 +78,824	+6%	+$1.11M	3.36%	9
2024 Q4	$16.3M	Buy	1,230,400 +851,654	+225%	+$14.6M	3.64%	9
2024 Q3	$7.29M	Buy	378,746 +8,746	+2%	+$181K	1.64%	18
2024 Q2	$7.6M	Buy	+370,000	New	+$7.74M	1.88%	18
2023 Q4	–	Sell	-20,000	Closed	-$290K	–	89
2023 Q3	$290K	Hold	20,000	–	–	0.11%	73
2023 Q2	$419K	Buy	+20,000	New	+$416K	0.14%	69
2022 Q3	–	Sell	-107,852	Closed	-$2.08M	–	94
2022 Q2	$2.08M	Buy	107,852 +6,405	+6%	+$107K	0.97%	40
2022 Q1	$1.76K	Buy	101,447 +1,447	+1%	+$24.4K	0.83%	33
2021 Q4	$2.19M	Buy	+100,000	New	+$1.85M	0.98%	37
2021 Q3	–	Sell	-34,727	Closed	-$596	–	107
2021 Q2	$596	Buy	34,727 +14,727	+74%	+$270K	0.29%	76
2021 Q1	$447K	Sell	20,000 -10,000	-33%	-$226K	0.25%	75
2020 Q4	$667K	Buy	+30,000	New	+$622K	0.41%	63